• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名急性新冠病毒感染患者的无痛性亚急性甲状腺炎：一个短暂事件

Painless Subacute Thyroiditis in a Patient With Acute COVID-19 Infection: A Transient Event.

作者信息

Dolkar Tsering, Jitidhar Fnu, Patel Meet J, Hamad Abubaker M, Salauddin Ferdous, Shiferaw-Deribe Zewge, Dogar Muhammad H

机构信息

Internal Medicine, One Brooklyn Health (OBH) Interfaith Medical Center, Brooklyn, USA.

Medicine, Memorial Hospital of Converse County, Douglas, USA.

出版信息

Cureus. 2022 Jul 16;14(7):e26924. doi: 10.7759/cureus.26924. eCollection 2022 Jul.

DOI:10.7759/cureus.26924
PMID:35983391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9377795/
Abstract

Coronavirus 2019 disease (COVID-19) is a highly contagious infectious disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). Although several articles have described the non-respiratory effects of COVID-19 in the past two years, there are few reports of COVID-19 associated with thyroiditis. We present a case of a middle-aged female patient with positive COVID-19 PCR associated with acute pulmonary embolism and thyroiditis. Three months ago, her baseline thyroid profile was normal. Thyroiditis induced elevated free thyroxine (FT4) and decreased thyroid-stimulating hormone (TSH) levels resolved with conservative management within six days.

摘要

2019冠状病毒病（COVID-19）是由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的一种高度传染性传染病。尽管在过去两年中有几篇文章描述了COVID-19的非呼吸道影响，但与甲状腺炎相关的COVID-19报道很少。我们报告一例中年女性患者，其COVID-19聚合酶链反应（PCR）检测呈阳性，同时伴有急性肺栓塞和甲状腺炎。三个月前，她的甲状腺功能基线正常。甲状腺炎导致游离甲状腺素（FT4）升高和促甲状腺激素（TSH）水平降低，经保守治疗在六天内恢复正常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/10ef647152ac/cureus-0014-00000026924-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/60166db833e8/cureus-0014-00000026924-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/03be69b8a44c/cureus-0014-00000026924-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/0e5e80b2c1c1/cureus-0014-00000026924-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/10ef647152ac/cureus-0014-00000026924-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/60166db833e8/cureus-0014-00000026924-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/03be69b8a44c/cureus-0014-00000026924-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/0e5e80b2c1c1/cureus-0014-00000026924-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2bc/9377795/10ef647152ac/cureus-0014-00000026924-i04.jpg

相似文献

1
Painless Subacute Thyroiditis in a Patient With Acute COVID-19 Infection: A Transient Event.一名急性新冠病毒感染患者的无痛性亚急性甲状腺炎：一个短暂事件
Cureus. 2022 Jul 16;14(7):e26924. doi: 10.7759/cureus.26924. eCollection 2022 Jul.
2
Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).SARS 和 2019 冠状病毒病（COVID-19）的甲状腺并发症。
Endocr J. 2021 Feb 28;68(2):129-136. doi: 10.1507/endocrj.EJ20-0443. Epub 2021 Jan 19.
3
Hashimoto's Thyroiditis Encephalopathy Induced by COVID-19 Infection.新冠病毒感染诱发的桥本甲状腺炎脑病
Cureus. 2022 Aug 26;14(8):e28419. doi: 10.7759/cureus.28419. eCollection 2022 Aug.
4
Long-term outcome of thyroid abnormalities in patients with severe Covid-19.严重 COVID-19 患者甲状腺异常的长期转归。
Eur Thyroid J. 2023 Mar 10;12(2). doi: 10.1530/ETJ-22-0200. Print 2023 Apr 1.
5
Subacute Thyroiditis After Sars-COV-2 Infection.感染 SARS-CoV-2 后发生亚急性甲状腺炎。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa276.
6
Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19.191 例 COVID-19 患者的甲状腺功能障碍与免疫谱、疾病状况和预后的关系。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e926-e935. doi: 10.1210/clinem/dgaa813.
7
Case Report: Subacute thyroiditis after receiving inactivated SARS-CoV-2 vaccine (BBIBP-CorV).病例报告：接种新型冠状病毒灭活疫苗（BBIBP-CorV）后发生亚急性甲状腺炎。
Front Med (Lausanne). 2022 Jul 22;9:918721. doi: 10.3389/fmed.2022.918721. eCollection 2022.
8
Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.接种 SARS-CoV-2 mRNA 疫苗后 Graves 病的发病：病例报告及文献复习。
Front Public Health. 2021 Nov 23;9:778964. doi: 10.3389/fpubh.2021.778964. eCollection 2021.
9
Subacute Thyroiditis After Severe Acute Respiratory Syndrome Coronavirus 2 Vaxzevria Vaccination in a Patient With Thyroid Autoimmunity.1例甲状腺自身免疫患者接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）Vaxzevria疫苗后发生亚急性甲状腺炎
Cureus. 2022 Feb 18;14(2):e22353. doi: 10.7759/cureus.22353. eCollection 2022 Feb.
10
Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.区分破坏所致甲状腺毒症和格雷夫斯甲状腺毒症的简单实用参数。
Clin Endocrinol (Oxf). 2002 Jul;57(1):51-8. doi: 10.1046/j.1365-2265.2002.01558.x.

引用本文的文献

1
Subacute thyroiditis as a post-COVID-19 complication: a systematic review.新冠后亚急性甲状腺炎并发症：一项系统综述
BMC Infect Dis. 2025 Jul 1;25(1):862. doi: 10.1186/s12879-025-10518-0.
2
Thyroid function during COVID-19 and post-COVID complications in adults: a systematic review.成人新冠病毒感染期间的甲状腺功能及新冠后并发症：一项系统综述
Front Endocrinol (Lausanne). 2025 Feb 4;15:1477389. doi: 10.3389/fendo.2024.1477389. eCollection 2024.
3
Long-Term Impacts of COVID-19 on Thyroid Health: Insights From Clinical Studies.新冠病毒病对甲状腺健康的长期影响：来自临床研究的见解

本文引用的文献

1
The Association of Subacute Thyroiditis with COVID-19: a Systematic Review.亚急性甲状腺炎与新型冠状病毒肺炎的关联：一项系统综述
SN Compr Clin Med. 2021;3(7):1515-1527. doi: 10.1007/s42399-021-00912-5. Epub 2021 Apr 29.
2
The cytokine storm and thyroid hormone changes in COVID-19.新型冠状病毒肺炎中的细胞因子风暴与甲状腺激素变化。
J Endocrinol Invest. 2021 May;44(5):891-904. doi: 10.1007/s40618-021-01506-7. Epub 2021 Feb 9.
3
Potential Interaction Between SARS-CoV-2 and Thyroid: A Review.新型冠状病毒与甲状腺之间潜在的相互作用：综述。
Cureus. 2024 Oct 14;16(10):e71469. doi: 10.7759/cureus.71469. eCollection 2024 Oct.
4
New-Onset Paroxysmal Atrial Fibrillation in a Healthy Male With Post-COVID-19 Painless Thyroiditis: A Case Report.一名患新冠后无痛性甲状腺炎的健康男性新发阵发性心房颤动：病例报告
Cureus. 2024 Aug 6;16(8):e66288. doi: 10.7759/cureus.66288. eCollection 2024 Aug.
5
Subacute thyroiditis following COVID-19: A systematic review.COVID-19 后亚急性甲状腺炎：系统评价。
Front Endocrinol (Lausanne). 2023 Apr 5;14:1126637. doi: 10.3389/fendo.2023.1126637. eCollection 2023.
6
A Rare Case of Painless Destructive Thyroiditis Resulting in Thyroid Storm.无痛破坏性甲状腺炎致甲状腺危象 1 例罕见报告
Intern Med. 2023 Nov 15;62(22):3373-3379. doi: 10.2169/internalmedicine.1496-22. Epub 2023 Apr 7.
Endocrinology. 2021 Mar 1;162(3). doi: 10.1210/endocr/bqab004.
4
Impact of COVID-19 on the thyroid gland: an update.新型冠状病毒肺炎对甲状腺的影响：最新进展。
Rev Endocr Metab Disord. 2021 Dec;22(4):803-815. doi: 10.1007/s11154-020-09615-z. Epub 2020 Nov 25.
5
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis.检测甲状腺细胞中的 SARS-CoV-2 受体 ACE-2 mRNA：COVID-19 相关亚急性甲状腺炎的一个线索。
J Endocrinol Invest. 2021 May;44(5):1085-1090. doi: 10.1007/s40618-020-01436-w. Epub 2020 Oct 6.
6
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.亚急性甲状腺炎是 SARS-CoV-2 感染的被低估表现吗？一项病例系列研究的启示。
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa537.
7
Endocrine Significance of SARS-CoV-2's Reliance on ACE2.SARS-CoV-2 依赖 ACE2 的内分泌学意义。
Endocrinology. 2020 Sep 1;161(9). doi: 10.1210/endocr/bqaa108.
8
Subacute Thyroiditis After Sars-COV-2 Infection.感染 SARS-CoV-2 后发生亚急性甲状腺炎。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa276.
9
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.SARS-CoV-2 细胞受体基因 ACE2 在多种人类组织中的表达。
Infect Dis Poverty. 2020 Apr 28;9(1):45. doi: 10.1186/s40249-020-00662-x.
10
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.利用人血管紧张素转化酶 2 进入 SARS-CoV-2 的结构和功能基础
Cell. 2020 May 14;181(4):894-904.e9. doi: 10.1016/j.cell.2020.03.045. Epub 2020 Apr 9.